Diabeloop, from project to people-first company.
Born out of a medical research project, Diabeloop SA gathers to date the skills and personalities of 50 team members.
Their mission? Make technological disruptive innovations accessible to people with Type 1 diabetes so they can live the life they want!
To fulfill this commitment, Diabeloop team works everyday with families and patients to co-build projects with real-life positive impact….
A French rising star with a worldwide ambition
Structured around a complementary executive team, the company relies on a solid network of partners to support its development.
Transforming diabetes management through tech innovation
Diabeloop benefits from its R&D expertise in order to provide type one patients with state-of-the-art algorithms integrated into safe and user-friendly medical devices.
The British medical journal devoted a comment to the DBLG1 Systemhttps://www.thelancet.com/journals/landig/article/PIIS2589-7500(19)30007-X/fulltext
Online technology news leader covers DBLG1 System CES presentationhttps://www.cnet.com/news/ces-2019-this-mobile-handset-aims-to-simplify-type-1-diabetes-management/
Dedicated piece on Diabeloop strategy in French financial daily
German edition publishes news on CE Mark and launch of second financing round
Major T1D american organization published a "breaking news" piece on DBLG1's CE mark
They talk about us
R&D Project Partnership JDRF, SFC Fluidics®, Percusense and Diabeloop
Born Global Award Start-up of the Year EY 2018
Jury Prize, Start-up of the Year SNITEM
Samsung Artificial Intelligence Award Vivatech 2018
BPI France employees "Coup de coeur" Prize 2017
Start-up of the Year Usine Nouvelle 2017
Trophée de l'Embarqué, Health Award
Awarding fundings in 2016-2017 and 2018-2019